There's not much you can do to
control sequence risk other than, perhaps, to try to time your retirement for a period when the stock market is strong.
The lack of
control over who can obtain genetic
sequences and have them produced by one of a handful of companies that custom - synthesize DNA for customers may pose
risks, Venter told the commission.